FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of ...
CNBC· 5 日前The Food and Drug Administration on Thursday pulled its authorization for AstraZeneca's ...
Cowen says buy Regeneron, success of drugs could help pharmaceutical stock
CNBC· 2 日前Regeneron 's stock could get a boost as one of its major drugs gains a competitive edge and ...
Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S.
The Wall Street Journal· 1 日前The arthritis therapy is coming up against its first so-called biosimilar, after more than $135 ...
Google's ex-CEO Eric Schmidt tapped for federal biotech commission that allows members to ...
CNBC· 1 日前On Dec. 30, leaders of the House and Senate Armed Services committees announced the selection ...
Humana profit beats estimates as investment income exceeds expectations
Reuters· 19 分鐘前Humana Inc (HUM.N) on Wednesday beat Wall Street estimates for quarterly profit as the health ...
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, ...
Forbes· 11 小時前Yesterday, Amgen announced that it would launch the U.S.’s first marketed Humira-referenced ...
EU drug regulator decides ongoing antibiotic shortage not a 'major event'- source
Reuters· 6 日前Europe's drug regulator has decided not to label the ongoing shortage of antibiotics in the ...
Amgen launches biosimilar version of AbbVie's Humira
Reuters· 1 日前Amgen Inc (AMGN.O) on Tuesday said it was launching Amjevita, or adalimumab-atto, a biosimilar ...
European shares edge up as industrials gain; Fed meet in focus
Reuters· 6 小時前European shares edged higher on Wednesday as industrial stocks gained, while investors awaited ...
Italy, Albania drug-trafficking network dismantled, says Europol
Reuters· 6 日前Law enforcement authorities have dismantled a network of drug traffickers in Italy and Albania, ...
